Related Experiment Video

Updated: Jul 6, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype

M E A Borm1, A A van Bodegraven, C J J Mulder

  • 1Department of Molecular Cell Biology and Immunology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.

Genes and Immunity
|March 15, 2008
PubMed

Insights

Mutations in NOD2 increase Crohn's disease risk by disrupting immune regulation. High doses of muramyl dipeptide (MDP) normally inhibit excessive immune responses via NOD2, a function lost in Crohn's disease patients.

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • NOD2 mutations are linked to Crohn's disease (CD), but the underlying mechanisms remain unclear.
  • Previous studies in mice suggested NOD2 negatively regulates Toll-like receptor 2 (TLR2) signaling, while human studies indicated synergy.
  • This discrepancy highlights the need to further investigate the complex interplay between NOD2 and TLR2 in human immune responses.

Purpose of the Study:

  • To investigate the dose-dependent interaction between NOD2 and TLR2 signaling in human monocytes.
  • To elucidate the role of NOD2 in regulating immune responses to muramyl dipeptide (MDP) in the context of TLR2 activation.
  • To understand how this regulatory mechanism is affected in patients with Crohn's disease.

Main Methods:

  • Human monocytes were stimulated with TLR2 agonists.
  • Dose-dependent effects of muramyl dipeptide (MDP) on cytokine production were assessed.
  • Responses were compared between healthy individuals and patients with NOD2-deficient Crohn's disease.

Main Results:

  • Low doses of MDP enhanced TLR2-induced cytokine production.
  • High doses of MDP significantly downregulated cytokine production in a NOD2-dependent manner.
  • This inhibitory effect of high-dose MDP was absent in monocytes from NOD2-deficient Crohn's disease patients.

Conclusions:

  • NOD2 acts as a crucial negative regulator of immune responses to high concentrations of bacterial components like MDP.
  • This NOD2-mediated inhibition serves as a safety mechanism to prevent excessive inflammation in the gut.
  • Loss of this regulatory function in NOD2-deficient Crohn's disease patients may contribute to chronic gut inflammation.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells09:51

Development and Functional Characterization of Murine Tolerogenic Dendritic Cells

Published on: May 18, 2018

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...